The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Designing sensitive and single-use biosensors for early diagnosis remains a major challenge. Scientists in China invented submonolayer lasers on optical fibers as ultrasensitive and disposable biosensors.
A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D.
Two Rutgers professors, both leading Alzheimer's disease researchers, have partnered with Tel Aviv University and Hebrew University to organize the US-Israel Alzheimer’s Disease Conference in Tel Aviv.
Researchers have discovered why a gene that, when mutated, is a common cause of two debilitating brain diseases.
Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short prompt from the user.
Nicolas Musi, MD, studies a spectrum of age-related disorders that can impact a healthy lifespan.
A team of University of Wisconsin–Madison scientists has developed the first 3D-printed brain tissue that can grow and function like typical brain tissue.
Hydrogen peroxide is crucial in cell metabolism, playing key roles in cell proliferation, differentiation, and migration. However, elevated levels of hydrogen peroxide (H2O2) are linked to several diseases, including cancer and neurodegenerative disorders like Alzheimer's and Parkinson's disease.
Left unchecked, hearing loss can lead to lead to social isolation and depression – two conditions proven to hasten dementia. A Penn State Health expert sounds off on what you can do about it.
University at Albany scientist Scott Tenenbaum, founder of UAlbany spinoff company sxRNA Technologies, Inc. (sxRNA Tech), has received $500,000 from the National Institute on Aging, part of the National Institutes of Health, to study how aging brain cells shape the progression of Alzheimer’s disease, and advance RNA technology that could inform new therapeutics to prevent and treat Alzheimer's and related dementias.
A new therapeutic for stroke based on University of Georgia research will soon enter clinical trials.
RUDN University chemists have obtained new azaheterocyclic compounds that inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), regulators of the central nervous system.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable Alzheimer’s-related (ADRD) hospitalizations.
Protein degraders offer a novel approach to targeting undruggable diseases by hijacking the cell's degradation machinery.
Nerve cells in the brain demand an enormous amount of energy to survive and maintain their connections for communicating with other nerve cells.
A new study from UC Davis Health and Oregon Health & Science University reveals significant disparities in dementia care.
Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.
A Beckman study led by Paul Bogdan and Florin and Sanda Dolcos suggests the moments that follow a distressing episode are more memorable than the moments leading up to it.
This research from UNC-Chapel Hill, published in the journal Nature Communications, opens the door to researching this wirelessly controlled patch to deliver on-demand treatments for neurodegenerative disorders, including Alzheimer’s disease.
UC Davis Health and Kaiser Permanente Division of Research received a $24 million grant from the National Institute on Aging, part of the NIH, to continue the Study of Healthy Aging in African Americans (STAR).
Approximately 23% of people diagnosed with Alzheimer’s disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Is it possible to amp up the energy production of mitochondria, the “power centers” of cells, without also boosting potentially harmful byproducts? If so, such a method could be used to treat a host of neurodegenerative diseases in which impaired mitochondria are believed to play a central role.
New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer’s disease, to a type of brain cancer known as glioma.
FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.
Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is designed to help medical staff tailor care to best serve these patients.
New understanding of a gene that is linked to some forms of dementia and other age-related diseases gives scientists fresh hope that action can be taken against these diseases long before the onset of symptoms.
Irvine, Calif., Jan. 8, 2024 — Additional staffing alone will not be sufficient to bridge the quality-of-care and health outcome disparities among nursing home facilities with varying percentages of residents with dementia, according to a first-of-its-kind study led by the University of California, Irvine. Specialized training, an easy-to-navigate environment and staff stability are also critical to meeting the unique challenges presented by this population.
People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according to new research published in the January 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that sleep quality causes cognitive decline. It only shows an association.
Our memories are rich in detail: we can vividly recall the color of our home, the layout of our kitchen, or the front of our favorite café. How the brain encodes this information has long puzzled neuroscientists.
A surprising MIT study published in Nature at the end of 2016 helped to spur interest in the possibility that light flickering at the frequency of a particular gamma-band brain rhythm could produce meaningful therapeutic effects for people with Alzheimer’s disease.
WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ Sciences has acquired majority ownership in the Alzheimer's Disease (AD) diagnostics company, Molecular Stethoscope, Inc., which is now renamed Superfluid Diagnostics, Inc. The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) participated in the Series A financing.
University of Virginia Alzheimer’s researchers have discovered how harmful tau proteins damage the essential operating instructions for our brain cells, a finding which could lead to new treatments.
Quality of life for people with dementia living in residential and nursing home care substantially improved after staff took part in a digital training programme that was specially adapted to Covid-19 restrictions. The training also led to a significant drop in the prescription of potentially harmful sedative medications to residents.
UCLA Health dementia care specialists say caregiving and holiday festivities do not have to be mutually exclusive, but do require some adaptations to make the season enjoyable for all.
A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Alzheimer’s disease (AD) is associated with damaging protein aggregates in the brain, with β-amyloid (Aβ) aggregates called plaques being the key pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the treatment of heart failure.
Neurologists often diagnose Alzheimer’s disease after evaluating patients during lengthy, in-person office visits.
University of West Florida faculty and undergraduate students recently developed Pulsed Medical LED goggles for the early detection of Alzheimer’s Disease.
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
Physical exercise is associated with a variety of positive health aspects. Numerous studies have shown that regular physical activity has a preventive effect on cardiovascular diseases, diabetes, cancer, high blood pressure and obesity.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
